Hims Hers Health (HIMS) had the highest return on January 2, 2024 by a large-cap US stock, returning 9.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Hims Hers Health (HIMS) | 1/2/2024 | 9.55% |
Celsius (CELH) | 1/2/2024 | 9.19% |
BioNTech SE (BNTX) | 1/2/2024 | 6.82% |
Viatris (VTRS) | 1/2/2024 | 5.56% |
Emera (EMA) | 1/2/2024 | 5.38% |
Las Vegas Sands (LVS) | 1/2/2024 | 4.95% |
Incyte (INCY) | 1/2/2024 | 4.9% |
Wynn Resorts (WYNN) | 1/2/2024 | 4.15% |
Biogen (BIIB) | 1/2/2024 | 3.94% |
Merck (MRK) | 1/2/2024 | 3.74% |
Tapestry (TPR) | 1/2/2024 | 3.69% |
Cheniere Energy Partners (CQP) | 1/2/2024 | 3.64% |
EnergySolutions (ES) | 1/2/2024 | 3.63% |
Dominion Energy (D) | 1/2/2024 | 3.59% |
Tyson Foods (TSN) | 1/2/2024 | 3.58% |
Regeneron Pharmaceuticals (REGN) | 1/2/2024 | 3.56% |
Amgen (AMGN) | 1/2/2024 | 3.52% |
Hershey (HSY) | 1/2/2024 | 3.5% |
United Therapeutics (UTHR) | 1/2/2024 | 3.47% |
Citigroup (C) | 1/2/2024 | 3.39% |
Kellanova (K) | 1/2/2024 | 3.35% |
Ascendis Pharma A-S (ASND) | 1/2/2024 | 3.22% |
AbbVie (ABBV) | 1/2/2024 | 3.18% |
Verizon Communications (VZ) | 1/2/2024 | 3.05% |
Altria (MO) | 1/2/2024 | 3.02% |
Large-cap stocks are treated as having a market cap of $10B+.
